Hypertrophic cardiomyopathy (HCM) is a complex genetic cardiovascular disease that often remains under-recognised, with ongoing challenges in diagnosis, risk stratification, and treatment. The HCM Knowledge Track brings together expert-selected resources — from congress presentations and trial updates to imaging insights, patient perspectives, and debates on therapeutic strategies. It offers a structured view of current evidence to support your understanding of diagnosis, guide your awareness of therapeutic advances, and broaden your perspective on expert debates relevant to practice.